BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35874956)

  • 1. Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19.
    He W; Gao Y; Zhou J; Shi Y; Xia D; Shen HM
    Int J Biol Sci; 2022; 18(12):4690-4703. PubMed ID: 35874956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of SARS-CoV-2 ORF7a in autophagy flux disruption: implications for viral infection and pathogenesis.
    Li S; Zhang H; Li W; Zhai J; Li X; Zheng C
    Autophagy; 2024 Jun; 20(6):1449-1451. PubMed ID: 38361390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules.
    Gorshkov K; Chen CZ; Bostwick R; Rasmussen L; Tran BN; Cheng YS; Xu M; Pradhan M; Henderson M; Zhu W; Oh E; Susumu K; Wolak M; Shamim K; Huang W; Hu X; Shen M; Klumpp-Thomas C; Itkin Z; Shinn P; Carlos de la Torre J; Simeonov A; Michael SG; Hall MD; Lo DC; Zheng W
    ACS Infect Dis; 2021 Jun; 7(6):1389-1408. PubMed ID: 33346633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
    Bestion E; Zandi K; Belouzard S; Andreani J; Lepidi H; Novello M; Rouquairol C; Baudoin JP; Rachid M; La Scola B; Mege JL; Dubuisson J; Schinazi RF; Mezouar S; Halfon P
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.
    Yang N; Shen HM
    Int J Biol Sci; 2020; 16(10):1724-1731. PubMed ID: 32226290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis.
    Li S; Li X; Liang H; Yu K; Zhai J; Xue M; Luo Z; Zheng C; Zhang H
    J Med Virol; 2023 Nov; 95(11):e29200. PubMed ID: 37916857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Antiviral Strategy Exploiting Dependence of SARS-CoV-2 Replication on Lysosome-Based Pathway.
    Lan Y; He W; Wang G; Wang Z; Chen Y; Gao F; Song D
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.
    Rein T
    J Cell Biochem; 2022 Feb; 123(2):155-160. PubMed ID: 34668225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.
    Bonam SR; Muller S; Bayry J; Klionsky DJ
    Autophagy; 2020 Dec; 16(12):2260-2266. PubMed ID: 32522067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
    Ballout RA; Sviridov D; Bukrinsky MI; Remaley AT
    FASEB J; 2020 Jun; 34(6):7253-7264. PubMed ID: 32367579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
    Morris G; Athan E; Walder K; Bortolasci CC; O'Neil A; Marx W; Berk M; Carvalho AF; Maes M; Puri BK
    Life Sci; 2020 Dec; 262():118541. PubMed ID: 33035581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and clinical implication of autophagy in COVID-19.
    Shan T; Li LY; Yang JM; Cheng Y
    Virol J; 2023 Jun; 20(1):125. PubMed ID: 37328875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights.
    Devarajan A; Vaseghi M
    Redox Biol; 2021 Jan; 38():101810. PubMed ID: 33360293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
    Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32862840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional interplay between SARS-CoV-2 and autophagy.
    Zhou H; Hu Z; Castro-Gonzalez S
    mBio; 2023 Aug; 14(4):e0102023. PubMed ID: 37436071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic COVID-19, an update of current status and new therapeutic strategies.
    Vitiello A; La Porta R; Trama U; Ferrara F; Zovi A; Auti AM; Di Domenico M; Boccellino M
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1159-1165. PubMed ID: 35779085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy in Inflammatory Response against SARS-CoV-2.
    Resnik R; Lopez Mingorance F; Rivera F; Mitchell F; Gonzalez CD; Vaccaro MI
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy and SARS-CoV-2-Old Players in New Games.
    Ivanova T; Mariienko Y; Mehterov N; Kazakova M; Sbirkov Y; Todorova K; Hayrabedyan S; Sarafian V
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Efficacy of Molnupiravir for COVID-19 Treatment.
    Bai Y; Shen M; Zhang L
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.